The first life science tenant at Harvard’s new Allston development is a research center that could eventually become home to ...

A four-year battle over one of the most ubiquitous patents in biotech ended with the US Patent and Trademark Office (USPTO) coming down on Genentech's side. The decision, reached in February ...

Roche’s U.S. biotech subsidiary Genentech has wiped its website of past diversity reports as the company’s diversity and inclusion (D&I) page undergoes construction. “The page that is under ...

And just like Genentech did for biotech, these companies aren't just creating products, they're building entirely new categories. As we enter 2025, the confluence of scientific advancement ...

Genentech disclosed in regulatory filings this ... “As we continue to reimagine musculoskeletal care, we are also committed ...

Genentech raised nearly $2 billion during its second initial public offering (IPO) on July 20 when Roche Holding refloated part of the company after acquiring all outstanding shares in June ...

(RTTNews) - Genentech, a member of the Roche Group (RHHBY), announced new positive data from Stage 2 and Stage 3 of the National Institutes of Health (NIH)-sponsored Phase III OUtMATCH study ...